Nurix Therapeutics’ $160.4 Million Follow-on Offering

Davis Polk advised the joint book-running managers and representatives of the several underwriters in the offering.Nurix Therapeutics, Inc. completed its follow-on offering of 5,175,000 shares of…

This content is for members only.
Login to Read More Join Now
Martina Bellini

Author: Martina Bellini

This content is for members only.
Login to Read More Join Now